arXiv · 2611.14560
AVA: Agentic Variant Adjudication for Automated, Auditable Read-Level Review in Cancer Diagnostic Sequencing
Abstract
Identifying a tumor's DNA mutations is central to cancer diagnosis and treatment, but distinguishing genuine mutations from sequencing artifacts is error-prone. In practice, genuine mutations are identified using fixed variant-allele-frequency (VAF) and depth thresholds which cannot separate artifacts from genuine mutations in the borderline low-VAF zone where they overlap. A laboratory specialist must manually inspect the read-level sequencing data, a slow step that has high inter-rater variability and causes diagnosis delays. We present AVA: Agentic Variant Adjudication; an agentic framework that automates this read-level inspection with subagents that reason over evidence, generate investigative code, and return a real-or-artifact adjudications with an auditable reasoning trace all without training on existing data. On both the SEQC2 DNA-seq benchmark and patient RNA-seq data, restricted to a subsample of borderline variants where thresholds fail, both closed-source (Claude Sonnet 5) and open-weight (GLM 5.3 Flash and Gemma 4 31b) agents outperform the best achievable VAF/depth thresholds. Ultimately, AVA is suited for privacy-constrained clinical deployment, since the framework can run on locally deployed open-weight models with descriptive reasoning traces to keep specialists in the loop.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Caleb Chin, Sidharth Gupta, Arun K Anguraj Vadivel, Robert Siddaway, Siddharth Arya, Arianna He, Peter Zhukovsky, Cynthia Hawkins. 2026-11-05. AVA: Agentic Variant Adjudication for Automated, Auditable Read-Level Review in Cancer Diagnostic Sequencing. https://arxiv.science/abs/2611.14560
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite arXiv Science by Indiciae: BibTeX · RIS.